693245-65-7 Usage
Uses
Used in Organic Synthesis:
2H-PYRAN-4-AMINE, TETRAHYDRO-4-METHYLis employed as a key intermediate in organic synthesis for the creation of various chemical compounds. Its unique structure allows for versatile reactions and the formation of a wide range of products, making it valuable in the synthesis of complex organic molecules.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 2H-PYRAN-4-AMINE, TETRAHYDRO-4-METHYLis used as a building block in the development of new drugs and pharmaceuticals. Its heterocyclic amine nature provides a foundation for the design of novel therapeutic agents, potentially leading to breakthroughs in medicinal chemistry.
Used in Drug Development:
2H-PYRAN-4-AMINE, TETRAHYDRO-4-METHYLis utilized in the research and development of new drugs, where its structural properties can be leveraged to create molecules with specific biological activities. 2H-PYRAN-4-AMINE, TETRAHYDRO-4-METHYLmay contribute to the discovery of new treatments for various diseases and conditions, enhancing the pharmaceutical arsenal against health challenges.
Check Digit Verification of cas no
The CAS Registry Mumber 693245-65-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,9,3,2,4 and 5 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 693245-65:
(8*6)+(7*9)+(6*3)+(5*2)+(4*4)+(3*5)+(2*6)+(1*5)=187
187 % 10 = 7
So 693245-65-7 is a valid CAS Registry Number.
InChI:InChI=1/C6H13NO/c1-6(7)2-4-8-5-3-6/h2-5,7H2,1H3
693245-65-7Relevant academic research and scientific papers
1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-ones and 1,5-dihydro-4H-pyrazolo[4,3-c]pyridin-4-ones as PDE1 Inhibitors
-
Paragraph 0231; 0232, (2017/10/30)
The present invention provides 1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-ones and 1,5-dihydro-4H-pyrazolo[4,3-c]pyridin-4-ones of formula (I) as PDE1 inhibitors and their use as a medicament, in particular for the treatment of neurodegenerative disorders and psychiatric disorders.
CHEMOKINE RECEPTOR BINDING COMPOUNDS
-
Page/Page column 121, (2010/11/26)
The present invention relates to chemokine receptor binding compounds, pharmaceutical compositions and their use. More specifically, the present invention relates to modulators of chemokine receptor activity, preferably modulators of CCR4 or CCR5. In one aspect, these compounds demonstrate protective effects against infection of target cells by a human immunodeficiency virus (HIV).
